デフォルト表紙
市場調査レポート
商品コード
907648

合法大麻 - 世界市場の見通し(2017年~2026年)

Legal Marijuana - Global Market Outlook (2017-2026)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 175 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
合法大麻 - 世界市場の見通し(2017年~2026年)
出版日: 2019年07月19日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の合法大麻市場は、2017年に127億8,000万米ドルと評価され、予測期間中においては21.9%のCAGRで推移し、2026年までに756億9,000万米ドル規模の市場に成長すると予測されています。大麻の合法化の拡大や、パーキンソン病、がん、関節炎、神経障害などの治療薬としての医療用大麻の普及などが当市場の主な成長要因となっています。

当レポートでは、世界の合法大麻市場を調査し、市場の概要、製品・種類・用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向の分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • 製品分析
  • 用途分析
  • 新興市場
  • 将来の市場シナリオ

第4章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係

第5章 世界の合法マリファナ市場:製品別

  • イントロダクション
  • オイル
  • チンキ剤
  • バッズ

第6章 世界の合法マリファナ市場:種類別

  • イントロダクション
  • 娯楽用
  • 医療用

第7章 世界の合法マリファナ市場:用途別

  • イントロダクション
  • がん
  • 神経障害
  • 慢性疼痛
  • その他

第8章 世界の合法マリファナ市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第9章 主な開発動向

  • 契約・パートナーシップ・コラボレーション・合弁事業
  • 買収・合併
  • 新製品の発売
  • 事業拡張
  • その他の主要戦略

第10章 企業プロファイル

  • Cannabis Sativa, Inc.
  • Aphria, Inc.
  • GW Pharmaceuticals, plc.
  • Maricann Group, Inc.
  • United Cannabis Corporation.
  • Canopy Growth Corporation.
  • Tikun Olam, Ltd.
  • Tilray
  • Aurora Cannabis
  • Lexaria Corp.
  • The Cronos Group
  • Organigram Holding, Inc.
  • ABcann Medicinals, Inc.
図表

List of Tables

  • 1 Global Legal Marijuana Market Outlook, By Region (2016-2026) ($MN)
  • 2 Global Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 3 Global Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 4 Global Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 5 Global Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 6 Global Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 7 Global Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 8 Global Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 9 Global Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 10 Global Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 11 Global Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 12 Global Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 13 Global Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
  • 14 North America Legal Marijuana Market Outlook, By Country (2016-2026) ($MN)
  • 15 North America Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 16 North America Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 17 North America Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 18 North America Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 19 North America Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 20 North America Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 21 North America Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 22 North America Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 23 North America Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 24 North America Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 25 North America Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 26 North America Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
  • 27 Europe Legal Marijuana Market Outlook, By Country (2016-2026) ($MN)
  • 28 Europe Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 29 Europe Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 30 Europe Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 31 Europe Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 32 Europe Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 33 Europe Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 34 Europe Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 35 Europe Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 36 Europe Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 37 Europe Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 38 Europe Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 39 Europe Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
  • 40 Asia Pacific Legal Marijuana Market Outlook, By Country (2016-2026) ($MN)
  • 41 Asia Pacific Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 42 Asia Pacific Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 43 Asia Pacific Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 44 Asia Pacific Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 45 Asia Pacific Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 46 Asia Pacific Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 47 Asia Pacific Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 48 Asia Pacific Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 49 Asia Pacific Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 50 Asia Pacific Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 51 Asia Pacific Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 52 Asia Pacific Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
  • 53 South America Legal Marijuana Market Outlook, By Country (2016-2026) ($MN)
  • 54 South America Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 55 South America Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 56 South America Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 57 South America Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 58 South America Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 59 South America Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 60 South America Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 61 South America Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 62 South America Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 63 South America Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 64 South America Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 65 South America Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
  • 66 Middle East & Africa Legal Marijuana Market Outlook, By Country (2016-2026) ($MN)
  • 67 Middle East & Africa Legal Marijuana Market Outlook, By Product (2016-2026) ($MN)
  • 68 Middle East & Africa Legal Marijuana Market Outlook, By Oils (2016-2026) ($MN)
  • 69 Middle East & Africa Legal Marijuana Market Outlook, By Tinctures (2016-2026) ($MN)
  • 70 Middle East & Africa Legal Marijuana Market Outlook, By Buds (2016-2026) ($MN)
  • 71 Middle East & Africa Legal Marijuana Market Outlook, By Marijuana Type (2016-2026) ($MN)
  • 72 Middle East & Africa Legal Marijuana Market Outlook, By Recreational Marijuana (2016-2026) ($MN)
  • 73 Middle East & Africa Legal Marijuana Market Outlook, By Medical Marijuana (2016-2026) ($MN)
  • 74 Middle East & Africa Legal Marijuana Market Outlook, By Medical Application (2016-2026) ($MN)
  • 75 Middle East & Africa Legal Marijuana Market Outlook, By Cancer (2016-2026) ($MN)
  • 76 Middle East & Africa Legal Marijuana Market Outlook, By Mental Disorders (2016-2026) ($MN)
  • 77 Middle East & Africa Legal Marijuana Market Outlook, By Chronic Pain (2016-2026) ($MN)
  • 78 Middle East & Africa Legal Marijuana Market Outlook, By Other Medical Applications (2016-2026) ($MN)
目次

According to Stratistics MRC, the Global Legal Marijuana Market is accounted for $12.78 billion in 2017 and is expected to reach $75.69 billion by 2026 growing at a CAGR of 21.9% during the forecast period. Some of the key factors influencing the market growth include Growing legalization in various countries and rising adoption of cannabis as a medical product for treating conditions such as Parkinson's disease, cancer, arthritis, and neurological disorders. However, stringent rules and regulations regarding the product sale and cultivation is restraining the market growth.

Based on the marijuana type, recreational is defined as any use of marijuana apart from medical purpose. Recreational use can range from it being a psychoactive drug to food ingredient. Few countries like Canada, Uruguay, Colombia, and some states in U.S. have legalized recreational cannabis. By Geography, North America is going to have a lucrative growth during the forecast period owing to the presence of a large customer pool and legalization of medical marijuana in U.S. and Canada. Currently 33 states in U.S. and District of Colombia have legalized cannabis in U.S. making it the largest market in the world.

Some of the key players in global Legal Marijuana market are Cannabis Sativa, Inc., Aphria, Inc., GW Pharmaceuticals, plc., Maricann Group, Inc., United Cannabis Corporation., Canopy Growth Corporation., Tikun Olam, Ltd., Tilray, Aurora Cannabis, Lexaria Corp., The Cronos Group, Organigram Holding, Inc. and ABcann Medicinals, Inc.

Products Covered:

  • Oils
  • Tinctures
  • Buds

Marijuana Types Covered:

  • Recreational Marijuana
  • Medical Marijuana

Medical Applications Covered:

  • Cancer
  • Mental Disorders
  • Chronic Pain
  • Other Medical Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Legal Marijuana Market, By Product

  • 5.1 Introduction
  • 5.2 Oils
  • 5.3 Tinctures
  • 5.4 Buds

6 Global Legal Marijuana Market, By Marijuana Type

  • 6.1 Introduction
  • 6.2 Recreational Marijuana
  • 6.3 Medical Marijuana

7 Global Legal Marijuana Market, By Application

  • 7.1 Introduction
  • 7.2 Cancer
  • 7.3 Mental Disorders
  • 7.4 Chronic Pain
  • 7.5 Other Medical Applications

8 Global Legal Marijuana Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Cannabis Sativa, Inc.
  • 10.2 Aphria, Inc.
  • 10.3 GW Pharmaceuticals, plc.
  • 10.4 Maricann Group, Inc.
  • 10.5 United Cannabis Corporation.
  • 10.6 Canopy Growth Corporation.
  • 10.7 Tikun Olam, Ltd.
  • 10.8 Tilray
  • 10.9 Aurora Cannabis
  • 10.10 Lexaria Corp.
  • 10.11 The Cronos Group
  • 10.12 Organigram Holding, Inc.
  • 10.13 ABcann Medicinals, Inc.